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ABSTRACT 
AIM: To document and compare current practice in nutrition assessment of Parkinson’s 
disease by dietitians in Australia and Canada in order to identify priority areas for review 
and development of practice guidelines and direct future research. 
METHODS: An online survey was distributed to DAA members and PEN subscribers 
through their email newsletters. The survey captured current practice in the phases of 
the Nutrition Care Plan. The results of the assessment phase are presented here. 
RESULTS: Eighty-four dietitians responded. Differences in practice existed in the 
choice of nutrition screening and assessment tools, including appropriate BMI ranges. 
Nutrition impact symptoms were commonly assessed, but information about 
Parkinson’s disease medication interactions were not consistently assessed. 
CONCLUSIONS: The variation in practice related to the use of screening and 
assessment methods may result in the identification of different goals for subsequent 
interventions. Even more practice variation was evident for those items more specific to 
Parkinson’s disease and may be due to the lack of evidence to guide practice. Further 
research is required to support decisions for nutrition assessment of Parkinson’s 
disease. 
KEY WORDS: Parkinson’s disease; nutrition assessment; evidence based practice; 
nutritional status; Clinical nutrition and dietetics 
 
 
 
INTRODUCTION 
Parkinson’s disease (PD) is increasing in prevalence globally as the population ages.(1,2) 
There are a number of aspects related to PD requiring nutrition management(3,4) but there is 
a paucity of quality evidence on which to base nutrition management of PD.  
The movement, or motor, symptoms include bradykinesia, akinesia, resting tremor, muscle 
rigidity and postural instability, and non-motor symptoms include depression, anxiety, 
dementia, loss of olfactory sense, dysphagia, slowed gastric motility (resulting in early satiety 
and constipation) and orthostatic hypotension. These may contribute to malnutrition. On the 
other hand, decreased voluntary physical activity and preference for sweet or fatty foods(5,6) 
may predispose people with Parkinson’s disease (PWP) to weight gain. 
Symptom management typically involves the use of dopaminergic medication, commonly in 
the form of levodopa(7), or dopamine agonists.(8) Long-term use of levodopa can result in 
motor fluctuations (medication becomes ineffective) and dyskinesias (involuntary 
movements)(7,9) while dopamine agonists can result in compulsive eating.(10) Deep brain 
stimulation surgery is also becoming more popular for symptom management, following 
which weight gain is commonly reported.(11)  
Due to slowed gastric motility, absorption of levodopa at the jejuno-duodenal border can be 
delayed if medication is taken with meals.(12) Therefore, taking levodopa medication 30-45 
minutes prior to a meal may improve the therapeutic response. Competitive absorption 
between levodopa and amino acids in protein-containing foods may also exacerbate motor 
fluctuations.(13) Modified protein diets have been suggested to manage this, which may 
result in reduced protein intake and compromised nutritional status if not managed 
appropriately. The symptoms and medical management, therefore, can result in either 
undernutrition or overnutrition while symptoms such as dysphagia and constipation require 
specific management.  
Nutrition assessment as part of Medical Nutrition Therapy (MNT) for PD should cover these 
nutrition issues for effective nutrition diagnosis and subsequent intervention planning. 
Investigating current nutrition-related practice will identify priority areas for review and 
development of practice guidelines and direct future research. The primary aim of this study 
was to document and compare current practice in nutrition assessment as part of the 
nutritional management of PWP by dietitians located in Australia and Canada and to 
determine the extent of practice variation between practice areas and countries.  
METHODS 
Members of the Dietitians Association of Australia (DAA) (n=4500) and subscribers of the 
Canadian Practice-based Evidence in Nutrition (PEN) service (n=3400, excluding DAA 
members) were approached separately by their respective email newsletters to complete an 
online survey. Email invitations were also sent separately to two DAA interest groups: 
disability and residential aged care. Informed consent was obtained as per protocol approved 
by the Queensland University of Technology Human Research Ethics Committee. 
Survey 
Key survey, a web-based survey creation tool, was used for the survey development. DAA 
members had 10 weeks, and PEN subscribers 4 weeks, to respond. The questions within the 
survey were presented within the 4 phases of the nutrition care plan (NCP): Nutrition 
Assessment, Nutrition Diagnosis, Nutrition Intervention and Nutrition 
Evaluation/Monitoring.(14) There were 39 questions with a mix of multiple-choice and 
open-ended questions. Information about demographics, practice setting, level of confidence 
in practice with PWP, commonly asked patient/client questions and information needs was 
obtained. The “clinical” practice setting represented the acute care setting. Nutrition 
assessment questions (n=12) covered malnutrition, anthropometric methods, 
nutrition-related symptoms, medications, biochemical measures, macro- and micro-nutrient 
intake and use of nutrition supplements. The questions about the nutrition diagnosis (n=1), 
nutrition intervention (n=11) and nutrition monitoring (n=3) phases are covered 
elsewhere.(intervention practice paper) Respondents were able to provide more than one 
response to the majority of questions. 
Statistical analyses 
Open-ended responses and those provided in the “Other” response choice were reviewed 
and categorised according to the researcher’s judgment. If the response was considered to 
be similar to an existing answer, it was included in the frequency reporting as a response to 
that question rather than in the “Other” category. The respondent from Singapore, a member 
of DAA, was included with the Australian respondents for all analyses.  
Results are presented as frequencies, and percentages may not total 100% for those 
questions where multiple responses were allowed. Chi-square tests were conducted to 
determine differences in responses between practice categories and country of practice or 
Fisher’s Exact tests when the cell count was less than 5. Statistical analysis was completed 
using SPSS Version 19 (SPSS Inc., Chicago, IL, USA). Statistical significance was set at 
p<0.05.  
RESULTS 
There were 84 total responses to the survey (1% response rate). The majority of respondents 
worked in Australia (79.8%), had worked in dietetics for more than five years (59.5%) and 
spent less than 25% of their working time with PWP (88.1%) (Table 1). Twenty-eight (33.3%) 
reported working in more than one area of practice. Significantly more of the Canadian 
dietitians reported working in the aged care setting (X2=7.42, p=.012) (Table 1). “Other” 
practice area responses included management, corporate, rehabilitation and mental health.  
Referrals primarily originated from other allied health professionals (63.1%), followed by other 
medical professionals (geriatricians and nursing staff) (39.3%), general practitioners (GP) 
(32.1%), neurologists (17.8%), self-referrals (11.9%) and community programs (4.8%). 
“Other” responses included referrals from routine nutrition screening in hospital (3.6%) and 
routine assessment in aged care facilities (9.5%). Referrals from GPs were reported 
significantly less by clinical dietitians (23.7% vs 52.0%, X2=6.44,p=.020) and significantly 
more frequently by community (64.7% vs 23.9%, X2=10.36,p=.002) and private practice (73.3% 
vs 23.2%, Fisher’s exact,p=.000) dietitians. Canadian dietitians reported significantly more 
referrals from “Other” sources (50.0% vs 14.7%, Fisher’s exact, p=.005). 
The majority of the respondents (79.8%) had medium to high level of confidence working with 
PWP. Confidence did not differ significantly based on years of experience or % of working 
time spent with PWP. Nearly all respondents (98.8%) reported a need for evidence-based 
guidelines for nutrition-related management of PD. As a group, self-initiated literature reviews 
and textbooks were the most commonly reported resources used to guide the nutrition 
management of PD (Table 1). The PEN resource was used significantly more by Canadian 
dietitians (X2=30.98,p=.000). 
The majority of respondents (82.1%) reported routine nutrition screening using a validated 
screening tool (92.9%) (Table 2). “Other” responses for screening tools included a 
facility/department-generated screening tool (4.8%), clinical judgment (1.2%) and nutrition 
assessment only (1.2%). The Malnutrition Screening Tool (MST)(15) was the most highly 
used screening tool overall (44.0%) (Table 2) and across the majority of the practice settings 
(Figure 1). There were significant differences between countries in the use of the MST 
(X2=15.56,p=.000); the Nutritional Risk Screening (NRS-2002) tool(16) (X2=5.78,p=.045) and 
the use of other screening tools (X2=9.50,p=.011) (Table 2). 
The Malnutrition Universal Screening Tool (MUST)(17) was used significantly more often by 
community-based respondents (29.4% vs 7.5%, X2=6.23,p=.013) (Figure 1). Respondents in 
aged care were significantly less likely to use the MST (16.7% vs 55.0%, X2=10.22,p=.002), 
and they were more likely to report not screening for nutritional risk (33.3% vs 11.7%, 
X2=4.60,p=.053).  
The majority of respondents (85.7%) reported routine nutrition assessment and the use of a 
validated assessment tool (91.7%) (Table 2). “Other” responses for assessment tools 
included a facility/department/individual-generated assessment tool (3.6%), clinical judgment 
(3.6%) and screening only (1.2%). The Subjective Global Assessment (SGA)(18) was the 
most highly used assessment tool overall (44.0%) (Table 2) and across the majority of the 
practice settings (Figure 2). There were significant differences between countries in the use 
of the SGA (X2=7.98,p=.005) and the use of “Other” assessment tools (X2=10.83,p=.005) 
(Table 2). Respondents in aged care were significantly less likely to use the SGA (16.7% vs 
55.0%, X2=10.22,p=.002) and more likely to use the MNA (45.8% vs 21.7%, X2=4.91,p=.035) 
(Figure 2). 
For wheelchair- or bed-bound patients/clients, weight was most often obtained by hoist or 
wheelchair scales (67.9%). Six (7.1%) reported the use of other measures (mid-arm or calf 
circumference). “Other” choices to document weight in these patients/clients included 
patient/carer/spouse self-report (8.3%), estimated based on recent weight changes (6.0%), 
medical records (4.8%) and do not obtain a weight (4.8%). To obtain height in patients/clients 
who were not mobile, 33.3% reported the use of ulna length followed by records (drivers 
license, medical records, etc) (23.8%), knee height (21.4%), demi-span (13.1%), n/a (all 
mobile; do not use height) (13.1%) and self-report (6.0%). 
Age-specific body mass index (BMI) categories were used by 26.2%. The most commonly 
used for older adults were 22-27kg/m2 (63.6%), 23-29kg/m2 (9.1%) and one each for 
22-25kg/m2 and Masters tables(19). Categories used among younger adults included 
20-25kg/m2 (45.5%) and 18.5-25kg/m2 (36.4%). When age was not taken into consideration, 
the most common BMI categories were 22-27kg/m2 (32.1%), 20-25kg/m2 (11.9%) and 
18.5-25kg/m2 (9.5%). Nine other BMI categories were used by 15.5% of the respondents. 
Three (3.6%) reported not using BMI. 
All respondents assessed nutrition impact symptoms (Table 2). Of these, early satiety, 
constipation and nausea/vomiting were significantly less likely to be assessed in the aged 
care setting (X2=7.49,p=.011; X2=6.89,p=.022; X2=8.98,p=.005). Private practice was the only 
area in which respondents reported not assessing macro- or micro-nutrients (13.3%, 
X2=9.42,p=.030) (Table 2). Information about timing of PD medications with meals and the 
use of vitamin and mineral supplements was also commonly collected (Table 2). Dietitians 
from Canada were significantly less likely to assess the timing of PD medications with meals 
(X2=6.63,p=.015). 
DISCUSSION  
This is the first survey to report the way in which dietitians assess nutrition-related issues in 
PWP. The results reflect the responses of dietitians of varying levels of experience and 
practicing in a number of settings in Australia and Canada and indicate that variation in 
practice does exist. 
This variation is particularly evident in the use of nutrition screening and assessment tools, 
which differed based on area and country of practice. The use of the MST in Australia may be 
explained by the fact that it was developed in Australia and is included in the Waterlow 
Pressure Ulcer/Injury Risk Assessment tool in acute care facilities,.  The MNA-SF and full 
MNA do not require specialised training, can be completed by other health professionals and 
therefore may be the best option in settings where others may complete screening, such as in 
aged care. This may explain the wide use in Canada where the majority of respondents 
worked in aged care. While the choice of screening and assessment tools should be specific 
to the setting and to the population,(20) none of the available tools have been validated for 
use in PD. Therefore, the current use of these tools may reflect what is perceived to be the 
best tool for the setting.  
There was greater reported variation in the use of BMI categories to identify underweight and 
overweight. Thirteen different BMI categories were reported along with the use of average 
weight and height values for adults aged 65 to 94 in 1960.(19) About a quarter of dietitians 
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also reported using different categories depending on the age of the PWP (<65 years or >/= 
65 years). Unfortunately, the survey did not ascertain on which evidence the choice of these 
categories was based or whether they were based on personal preference or experience. 
PD is accompanied by disability that can result in loss of mobility, and further variation was 
reported in the documenting of height and weight in PWP who were chair or bed bound 
potentially further confounding the use of BMI. 
The use of different screening and assessment tools/methods; height and weight 
measurements; and BMI categories across settings may present challenges in standardising 
the delivery and monitoring of nutrition-related care. Different methods to identify those in 
need of nutrition intervention may result in different interventions and inconsistent care by 
different dietitians for the same patient. This population could benefit from the use of a 
validated assessment tool that identifies nutrition risk independent of anthropometry. Current 
work underway to standardize the definition and assessment of nutrition risk(24) may assist 
with guidance for standardised practice globally and across practice settings.  
Country differences also existed in practice related to the assessment of medication and 
meal timing. The absorption of medication containing levodopa may be delayed by 
consumption of a meal.(12) Therefore, it has been recommended to take this medication ½ 
hour before a meal or about an hour after to ensure optimal therapeutic benefit. With more 
advanced disease and increasing and more frequent medication doses, the practice of 
separating meals and medication could become more important. The physical act of eating 
could also benefit from the patient being in an optimally medicated state. While ¾ of 
Australian dietitians assessed this timing, less than ½ of Canadian dietitians did. The majority 
of Canadian dietitians reported working in aged care settings where control of medications 
and meals are outside of the patient’s control. However, advocating for a change in those 
settings could potentially improve symptom control and subsequently dietary intake. 
Assessment of nutrition risk in PD should include documentation of the presence of nutrition 
impact symptoms, many of which occur more commonly than in other conditions. Previous 
research has identified that poor appetite, dysphagia, constipation and depressive symptoms 
play important roles in nutritional risk in PWP.(21)(Sheard, predictors) The current results 
support these findings with the symptoms of poor appetite, dysphagia and constipation the 
most commonly assessed by the responding dietitians. Mental health, however, was not as 
frequently assessed…The remainder of the nutrition impact symptoms were assessed at 
lower rates despite their high prevalence in PD. For example, early satiety(25) and loss of 
olfaction(26) are particularly common and can significantly influence intake.(27,28). 
A number of micro-nutrients have been identified as being important in PWP, including 
calcium,(29) vitamin D,(30) and vitamin B12.(31,32) However, these were not consistently 
assessed by the surveyed dietitians. The risk of osteoporosis and falls is higher in PWP,(33) 
highlighting the importance of adequate calcium intake and vitamin D status. Vitamin B12 
may be reduced due to interactions with medications(31,32) and by avoidance of 
protein-containing foods. This may result in symptoms similar to those of PD and treatment 
for worsening of PD symptoms rather than a vitamin deficiency.  
Nearly 100% of the dietitians reported the need for evidence-based guidelines to guide 
practice despite a medium to high level of confidence in the nutrition management of PD. This 
might be explained by the fact that over half reported relying on self-initiated literature 
reviews. Given that patients with PD represented a relatively small portion of total client time, 
reviewing and assessing literature may not be an efficient use of resources. Furthermore, 
about one third of respondents reported the use of internally developed guidelines. These 
could collectively contribute to a shared evidence resource such as the Practice in Evidence 
in Nutrition (PEN) resource developed by Dietitians Canada.  
Only a quarter of respondents reported the use of available guidelines. The NICE guidelines 
cover a range of topics and provide only limited nutrition-related information while few 
dietitians may have been aware of the guidelines developed by the British Dietetics 
Association. Lack of exposure to these and PEN at the time of the survey may have limited 
their use. Furthermore, there are currently limited practice questions available in PEN, and 
they do not reflect the complex and varied nutritional issues requiring management in 
Parkinson’s disease. However, consistency in practice across countries may be assisted by 
the move towards the use of PEN as a basis for evidence-based practice for both Canadian 
and Australian dietitians with the development of further practice questions.  
Further challenges exist relating to referrals from other health professionals. Responding 
dietitians reported receiving the majority of their referrals from other allied health 
professionals with only 20 and 30% from neurologists and general practitioners. Differences 
could be seen between practice areas, which is not surprising given that different referral 
pathways exist for each setting. However, a number of PWP requiring nutrition assistance 
may be missed, particularly in the community, if referrals are generated primarily from other 
allied health professionals. Monitoring of PD symptoms and treatment regime occurs on a 
regular basis and it is those health professionals who should be screening for nutrition-related 
issues and providing appropriate referrals. 
One limitation of the study is the low proportion of Canadian respondents, the majority of who 
were in aged care. Comparisons between countries and particularly between practice areas 
across countries were therefore limited. Furthermore, the survey questions related directly to 
the participating dietitians’ practice but did not capture whether other health professionals 
may be responsible for some aspects of nutrition-related care, such as nutrition screening. 
This may explain why the low rates of nutrition screening reported by some dietitians. The 
reason for referrals was also not obtained, which may have highlighted the nutrition-related 
issues considered important by other health professionals.  
CONCLUSION   
Understanding current practice can highlight those areas for which further evaluation and 
generation of evidence is required to support nutrition-related assessment. This study is the 
first to provide information about current practice in nutrition assessment in people with 
Parkinson’s disease and highlights the level of variation in practice. The use of different 
assessment methods may influence the goals of subsequent interventions, and the confusion 
about the most appropriate BMI range is a concern and may also affect assessment in other 
patient groups. For those items that are more specific to Parkinson’s disease, such as 
managing medication or the need to monitor specific micronutrients, there was more variation 
in practice, potentially due to the lack of experience and limited working exposure with PD.  
Further research should be conducted to provide evidence for the most appropriate tools in 
this population. Current guidelines should include information about all aspects of nutrition 
assessment of relevance in Parkinson’s disease.  
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Table 1: Practice characteristics of the dietitians (n=84) who responded to the online survey regarding nutrition management practices for 
Parkinson’s disease as a total sample and also by country 
Participant characteristics 
Total sample 
n (%) 
Australia 
n (%) 
Canada 
n (%) 
Country of practice    
Australia  67 (79.8) - - 
Canada 16 (19.0) - - 
Other: Singapore 1 (1.2) - - 
Years of experience as a dietitian    
<1 year 8 (9.5) 8 (11.8) 0 (0) 
1-5 years 26 (31.0) 20 (29.4) 6 (37.5) 
>5 years 50 (59.5) 40 (58.8) 10 (62.5) 
Area of dietetic practice    
Clinical (Acute Care) 59 (70.2) 48 (70.6) 11 (68.8) 
Community nutrition and public health 17 (20.2) 16 (23.5) 1 (6.3) 
Private Practice/Consultancy  15 (17.9) 12 (17.6) 3 (18.8) 
Food service and management 5 (6.0) 4 (5.9) 1 (6.3) 
Food industry 1 (1.2) 1 (1.5) 0 (0) 
Research  4 (4.8) 4 (5.9) 0 (0) 
Aged Care 24 (28.6)* 15 (22.1) 9 (56.3) 
Other 5 (6.0) 4 (5.9) 1 (6.3) 
Time spent with PD patients/clients    
0-25% 74 (88.1) 62 (91.2) 12 (75.0) 
> 25% 10 (11.9) 6 (8.8) 4 (25.0) 
Confidence in the nutritional management of people with PD    
1-2 (low level) 17 (20.2) 13 (19.1) 4 (25.0) 
3 (medium level) 43 (51.2) 34 (50.0) 9 (56.3) 
4-5 (high level) 24 (28.6) 21 (30.9) 3 (18.8) 
Resources currently used    
NICE clinical guidelines for management of Parkinson’s disease 15 (17.9) 14 (20.6) 1 (6.3) 
BDA Consensus on the Nutritional Management of Parkinson’s disease 10 (11.9) 10 (14.7) 0 (0) 
PEN Knowledge Pathway 19 (22.6)* 7 (10.3) 12 (75.0) 
Internal organisational practice guidelines/protocols 27 (32.1) 25 (36.8) 2 (12.5) 
Self-initiated literature review 45 (53.6) 34 (50.0) 11 (68.8) 
Textbooks 39 (46.4) 33 (48.5) 6 (37.5) 
Other 6 (7.1) 6 (8.8) 0 (0) 
BDA=British Dietetic Association, NICE=National Institute for Health and Clinical Excellence, PD=Parkinson’s disease, PEN=Practice-based 
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Table 2: Reported practice in the nutrition assessment phase of the Nutrition Care Plan (NCP) 
by 84 dietitians in Australia and Canada reported as a total sample and also by country as 
frequency (%) 
 
Total sample 
n (%) 
Australia 
n (%) 
Canada 
n (%) 
Method of nutrition screening    
Malnutrition Screening Tool (MST)(15) 37 (44.0)* 37 (54.4) 0 (0) 
Malnutrition Universal Screening Tool 
(MUST)(17) 
10 (11.9) 10 (14.7) 0 (0) 
Short Nutritional Assessment Questionnaire 
(SNAQ)(35) 
2 (2.4) 2 (2.9) 0 (0) 
Mini-Nutritional Assessment Short Form 
(MNA-SF)(36) 
25 (29.8) 18 (26.5) 7 (43.8) 
Nutritional Risk Screening (NRS-2002)(16) 5 (6.0)* 2 (2.9) 3 (18.8) 
Do not screen 15 (17.9) 12 (17.6) 3 (18.8) 
Other 6 (7.1)* 2 (2.9) 4 (25.0) 
Method of nutrition assessment    
Subjective Global Assessment (SGA)(18) 37 (44.0)* 35 (51.5) 2 (12.5) 
Patient-Generated Subjective Global 
Assessment (PG-SGA)(37) 
12 (14.3) 12 (17.6) 0 (0) 
Mini-Nutritional Assessment (MNA)(38) 24 (28.6) 18 (26.4) 6 (37.5) 
Do not assess 12 (14.3) 9 (13.2) 3 (18.8) 
Other 8 (9.5)* 3 (4.4) 5 (31.3) 
Nutrition impact symptoms    
Poor appetite 83 (98.8) 67 (98.5) 16 (100) 
Dysphagia 82 (97.6) 66 (97.1) 16 (100) 
Constipation 79 (94.0) 63 (92.6) 16 (100) 
Dentition 70 (83.3) 57 (83.8) 13 (81.3) 
Nausea/vomiting 64 (76.2) 54 (79.4) 10 (62.5) 
Mental health 57 (67.9) 44 (64.7) 13 (81.3) 
Diarrhoea 55 (65.5) 43 (63.2) 12 (75.0) 
Early satiety 54 (64.3) 44 (64.7) 10 (62.5) 
Dry mouth 51 (60.7) 40 (58.8) 11 (68.8) 
Taste changes 51 (60.7) 40 (58.8) 11 (68.8) 
Pain 39 (46.4) 31 (45.6) 8 (50.0) 
Lack of smell 30 (35.7) 24 (35.3) 6 (37.5) 
Do not assess 0 (0) 0 (0) 0 (0) 
Other 20 (23.8) 16 (23.5) 4 (25.0) 
Macro- and micro-nutrients    
Energy 82 (97.6) 67 (98.5) 15 (93.8) 
Protein 80 (95.2) 66 (97.1) 14 (87.5) 
Fat 30 (35.7) 24 (35.3) 6 (37.5) 
Carbohydrates 34 (40.5) 29 (42.6) 5 (31.3) 
Fibre 66 (78.6) 52 (76.5) 14 (87.5) 
Alcohol 29 (34.5) 25 (36.8) 4 (25.0) 
Calcium 52 (61.9) 40 (58.8) 12 (75.0) 
Iron 40 (47.6) 32 (47.1) 8 (50.0) 
Vitamin D 37 (44.0) 28 (41.2) 9 (56.3) 
Vitamin B6 6 (7.1) 6 (8.8) 0 (0) 
Vitamin B12 23 (27.4) 19 (27.9) 4 (25.0) 
Do not assess nutrients 2 (2.4) 1 (1.5) 1 (6.3) 
Other nutrients 5 (6.0) 4 (5.9) 1 (6.3) 
Timing of medications with food/meals 59 (70.2)* 52 (76.5) 7 (43.8) 
Use of vitamin/mineral/herbal supplements 66 (78.6) 52 (76.5) 14 (87.5) 
Collaboration with other health professionals    
Speech therapists 72 (85.7) 57 (83.8) 15 (93.8) 
Occupational therapists 50 (59.5) 41 (60.3) 9 (56.3) 
General practitioners 42 (50.0) 31 (46.3) 11 (68.8) 
Neurologists 28 (38.3) 22 (32.4) 6 (37.5) 
Other 28 (33.3) 23 (33.8) 5 (31.3) 
Work alone 3 (3.6) 3 (4.4) 0 (0) 
*Significant differences between country of practice, p<.05
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Figure 1: Nutrition Screening Tool use by area of practice expressed as a percentage of respondents in each area 
MNA-SF=Mini-Nutritional Assessment – Short Form; MST=Malnutrition Screening Tool; MUST=Malnutrition Universal Screening Tool; 
NRS= Nutritional Screening Initiative 
SNAQ excluded (n=2 only, clinical setting) 
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* Significant differences when compared with the rest of the practice areas, p<.05
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Figure 2: Nutrition Assessment Tool use by area of practice expressed as a percentage of respondents in each area 
MNA=Mini-Nutritional Assessment; PG-SGA=Patient-Generated Subjective Global Assessment; SGA=Subjective Global Assessment 
* Significant differences when compared with the rest of the practice areas, p<.05
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